GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $620,000 | +2.0% | 14,239 | +1.9% | 0.00% | +100.0% |
Q1 2022 | $608,000 | -9.8% | 13,973 | -8.5% | 0.00% | 0.0% |
Q4 2021 | $674,000 | +23.9% | 15,263 | +7.2% | 0.00% | 0.0% |
Q3 2021 | $544,000 | -5.7% | 14,233 | -1.8% | 0.00% | 0.0% |
Q2 2021 | $577,000 | +29.4% | 14,490 | +15.9% | 0.00% | 0.0% |
Q1 2021 | $446,000 | -9.9% | 12,507 | -6.9% | 0.00% | 0.0% |
Q4 2020 | $495,000 | -1.4% | 13,437 | +0.7% | 0.00% | 0.0% |
Q3 2020 | $502,000 | -7.9% | 13,344 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $545,000 | +10.1% | 13,344 | +2.1% | 0.00% | 0.0% |
Q1 2020 | $495,000 | -29.0% | 13,073 | -11.9% | 0.00% | 0.0% |
Q4 2019 | $697,000 | +1.9% | 14,841 | -7.6% | 0.00% | 0.0% |
Q3 2019 | $684,000 | +7.2% | 16,066 | +0.8% | 0.00% | 0.0% |
Q2 2019 | $638,000 | -9.5% | 15,946 | -5.4% | 0.00% | -33.3% |
Q1 2019 | $705,000 | -5.1% | 16,848 | -13.4% | 0.00% | 0.0% |
Q4 2018 | $743,000 | -2.9% | 19,461 | +2.2% | 0.00% | 0.0% |
Q3 2018 | $765,000 | +2.5% | 19,046 | +2.9% | 0.00% | 0.0% |
Q2 2018 | $746,000 | +16.6% | 18,506 | +13.2% | 0.00% | +50.0% |
Q1 2018 | $640,000 | +8.1% | 16,352 | -2.1% | 0.00% | 0.0% |
Q4 2017 | $592,000 | -36.1% | 16,701 | -26.8% | 0.00% | -50.0% |
Q3 2017 | $926,000 | -25.3% | 22,814 | -20.6% | 0.00% | -20.0% |
Q2 2017 | $1,239,000 | +25.7% | 28,734 | +22.9% | 0.01% | +25.0% |
Q1 2017 | $986,000 | -7.9% | 23,378 | -15.9% | 0.00% | -20.0% |
Q4 2016 | $1,071,000 | -34.4% | 27,785 | -26.6% | 0.01% | -37.5% |
Q3 2016 | $1,632,000 | -30.6% | 37,857 | -30.2% | 0.01% | -38.5% |
Q2 2016 | $2,353,000 | +9.7% | 54,271 | +2.7% | 0.01% | +8.3% |
Q1 2016 | $2,144,000 | +0.8% | 52,840 | +0.3% | 0.01% | 0.0% |
Q4 2015 | $2,127,000 | +100.7% | 52,696 | +91.2% | 0.01% | +100.0% |
Q3 2015 | $1,060,000 | -14.8% | 27,561 | -7.8% | 0.01% | 0.0% |
Q2 2015 | $1,244,000 | -3.3% | 29,883 | +7.2% | 0.01% | -14.3% |
Q1 2015 | $1,286,000 | +5.6% | 27,870 | -2.3% | 0.01% | 0.0% |
Q4 2014 | $1,218,000 | -55.1% | 28,516 | -51.7% | 0.01% | -12.5% |
Q3 2014 | $2,712,000 | +67.8% | 59,006 | +95.2% | 0.01% | -20.0% |
Q2 2014 | $1,616,000 | -1.1% | 30,230 | -1.0% | 0.01% | -9.1% |
Q1 2014 | $1,634,000 | -2.9% | 30,527 | -3.0% | 0.01% | -8.3% |
Q4 2013 | $1,683,000 | +8.1% | 31,459 | +1.3% | 0.01% | -7.7% |
Q3 2013 | $1,557,000 | +0.9% | 31,070 | +0.6% | 0.01% | -7.1% |
Q2 2013 | $1,543,000 | – | 30,870 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |